Presentation Information

[O4-02]Rational design of lipid nanoparticle-mRNA vaccine with reduced reactogenicity and preserved immunogenicity through immune profiling

*Takayuki Matsumura1, Tomohiro Takano1, Yoshimasa Takahashi1 (1. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases (Japan))

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in